XINGANJIANG
873167
INNOVATIVE DATA
835305
CHENGUANG MEDICAL
430300
4
Hangzhou Gaoxin Materials Technology
300478
5
Beijing Philisense Technology
300287
(FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | |
---|---|---|---|---|---|---|---|---|---|---|
Total revenue | 5.20%274.88M | 12.30%73.03M | 12.78%69.49M | 2.54%67.28M | -5.73%65.09M | -10.95%261.29M | -12.22%65.03M | -12.63%61.61M | -12.66%65.61M | -6.33%69.04M |
Operating revenue | 5.20%274.88M | 12.30%73.03M | 12.78%69.49M | 2.54%67.28M | -5.73%65.09M | -10.95%261.29M | -12.22%65.03M | -12.63%61.61M | -12.66%65.61M | -6.33%69.04M |
Cost of revenue | 2.98%53.25M | 9.11%13.99M | 4.32%13.39M | 2.46%13.06M | -3.71%12.81M | -4.03%51.71M | -7.85%12.82M | -2.28%12.84M | -8.25%12.74M | 2.82%13.31M |
Gross profit | 5.75%221.63M | 13.08%59.04M | 15.01%56.1M | 2.56%54.22M | -6.21%52.27M | -12.51%209.58M | -13.23%52.21M | -15.00%48.77M | -13.66%52.87M | -8.28%55.74M |
Operating expense | -6.53%225.52M | -2.62%58.05M | -4.86%56.1M | -9.67%55.43M | -8.77%55.94M | -0.67%241.26M | -8.68%59.61M | -2.97%58.97M | 2.88%61.37M | 7.23%61.32M |
Selling and administrative expenses | -4.95%150.79M | -0.81%39.58M | -2.37%37.45M | -8.69%36.73M | -7.78%37.04M | 1.49%158.65M | -6.75%39.9M | -0.87%38.36M | 5.78%40.22M | 9.12%40.17M |
-Selling and marketing expense | -3.00%122.45M | 2.00%32.51M | -0.10%30.5M | -6.81%29.74M | -6.95%29.7M | -0.23%126.24M | -2.07%31.87M | -2.81%30.53M | -1.16%31.92M | 5.40%31.92M |
-General and administrative expense | -12.55%28.34M | -11.94%7.07M | -11.20%6.95M | -15.93%6.98M | -11.01%7.34M | 8.80%32.41M | -21.61%8.03M | 7.50%7.82M | 44.80%8.31M | 26.35%8.25M |
Research and development costs | -9.55%74.72M | -6.29%18.47M | -9.51%18.65M | -11.54%18.7M | -10.66%18.9M | -4.56%82.62M | -12.34%19.71M | -6.65%20.61M | -2.23%21.14M | 3.83%21.15M |
Operating profit | 87.73%-3.89M | 113.39%991K | 99.94%-6K | 85.78%-1.21M | 34.37%-3.66M | -848.79%-31.68M | -44.93%-7.4M | -200.41%-10.2M | -639.34%-8.5M | -255.59%-5.58M |
Net non-operating interest income expense | 18.51%16.55M | 8.87%3.57M | 31.21%4.96M | 29.19%4.42M | 3.35%3.61M | 108.96%13.97M | 404.46%3.28M | 179.85%3.78M | 14.50%3.42M | 105.59%3.49M |
Non-operating interest income | 16.86%16.55M | --3.57M | ---- | 29.19%4.42M | 3.35%3.61M | 105.54%14.16M | ---- | ---- | 14.50%3.42M | 105.59%3.49M |
Total other finance cost | ---- | ---- | -31.21%-4.96M | ---- | ---- | -4.83%197K | --10.89M | ---3.78M | ---- | ---- |
Other net income (expense) | -102.92%-40K | |||||||||
Gain on sale of security | ---- | ---- | ---- | ---- | ---- | -102.92%-40K | ---- | ---- | ---- | ---- |
Income before tax | 171.34%12.67M | 209.53%4.56M | 177.14%4.95M | 163.14%3.21M | 97.37%-55K | -476.68%-17.75M | -34.76%-4.16M | -213.99%-6.42M | -211.38%-5.08M | -139.55%-2.09M |
Income tax | 72.71%6.63M | 25.09%2.11M | 317.32%1.81M | 112.38%1.54M | 17.76%1.17M | -21.36%3.84M | 63.06%1.69M | -52.93%433K | -48.44%727K | -34.59%991K |
Net income | 127.97%6.04M | 141.91%2.45M | 145.89%3.14M | 128.65%1.66M | 60.34%-1.22M | -12,906.02%-21.59M | -41.85%-5.85M | -131.14%-6.85M | -284.26%-5.81M | -181.72%-3.08M |
Net income continuous Operations | 127.97%6.04M | 141.91%2.45M | 145.89%3.14M | 128.65%1.66M | 60.34%-1.22M | -12,906.02%-21.59M | -41.85%-5.85M | -131.14%-6.85M | -284.26%-5.81M | -181.72%-3.08M |
Minority interest income | ||||||||||
Net income attributable to the parent company | 127.97%6.04M | 141.91%2.45M | 145.89%3.14M | 128.65%1.66M | 60.34%-1.22M | -12,906.02%-21.59M | -41.85%-5.85M | -131.14%-6.85M | -284.26%-5.81M | -181.72%-3.08M |
Preferred stock dividends | ||||||||||
Other preferred stock dividends | ||||||||||
Net income attributable to common stockholders | 127.97%6.04M | 141.91%2.45M | 145.89%3.14M | 128.65%1.66M | 60.34%-1.22M | -12,906.02%-21.59M | -41.85%-5.85M | -131.14%-6.85M | -284.26%-5.81M | -181.72%-3.08M |
Basic earnings per share | 128.00%0.14 | 142.86%0.06 | 143.75%0.07 | 130.77%0.04 | 57.14%-0.03 | -13,435.46%-0.5 | -55.56%-0.14 | -128.57%-0.16 | -285.71%-0.13 | -187.50%-0.07 |
Diluted earnings per share | 128.00%0.14 | 142.86%0.06 | 143.75%0.07 | 130.77%0.04 | 57.14%-0.03 | -13,435.46%-0.5 | -55.56%-0.14 | -128.57%-0.16 | -285.71%-0.13 | -187.50%-0.07 |
Dividend per share | ||||||||||
Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Audit Opinions | -- | -- | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- |